Subscribe to RSS

DOI: 10.1055/s-0044-1795094
Chemotherapy-Induced Fingerprint Effacement Leading to Deprivation of Health Insurance: A Case Series and Review of Literature
Funding None.
Abstract
Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PMJAY) is a game changer for the Indian health care system, where patients with cancer are the major beneficiaries. Some intrinsic procedural shortcomings are restricting the beneficiaries to utilize it optimally. We report a case series of patients receiving chemotherapy who had developed adermatoglyphia because of chemotherapeutic treatment. Therefore, these patients became ineligible for getting the benefits of PMJAY, because of failure of the biometric system to recognize their fingerprints. Hence, patient treatment could not be completed. As a solution, we suggest that the alternatives to fingerprint recognition like face recognition and iris scanning be incorporated into the biometric system to ensure continuous benefit of PMJAY to such patients.
Authors' Contributions
The manuscript has been read and approved by all the authors, and each author believes that the manuscript represents honest work.
Patient Consent
Patient consent was taken before the preparation of the manuscript.
Publication History
Article published online:
25 November 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 National Portal of India. Ayushman Bharat: National Health Protection Mission. Accessed November 6, 2024 at: https://www.india.gov.in/spotlight/ayushman-bharat-national-health-protection-mission
- 2 Canscreen5. Fact sheets. Accessed November 6, 2024 at: https://canscreen5.iarc.fr/?page=factsheets
- 3 Bajeli-Datt K. Cancer, heart patients top Ayushman Bharat-PM-JAY health insurance scheme. The New Indian Express. 2022. Accessed November 6, 2024 at: https://www.newindianexpress.com/thesundaystandard/2022/jul/24/cancer-heart-patients-top-ayushman-bharat-pm-jay-health-insurance-scheme-2479920.html
- 4 Huang J, Ye S, Feng S, Zheng M, Zhong M. Prevalence of hand-foot syndrome following chemotherapy for colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2023; 38 (01) 61
- 5 Al-Ahwal MS. Chemotherapy and fingerprint loss: beyond cosmetic. Oncologist 2012; 17 (02) 291-293
- 6 Azadeh P, Dashti-Khavidaki S, Joybari AY. et al. Fingerprint changes among cancer patients treated with paclitaxel. J Cancer Res Clin Oncol 2017; 143 (04) 693-701
- 7 van Doorn L, Veelenturf S, Binkhorst L, Bins S, Mathijssen R. Capecitabine and the risk of fingerprint loss. JAMA Oncol 2017; 3 (01) 122-123
- 8 The BMJ. Concerns about loss of fingerprints in the whole-course management model for breast cancer. 2024. Accessed November 6, 2024 at: https://www.bmj.com/content/351/bmj.h6023/rr
- 9 El-Abed M, Charrier C, Rosenberger C. Evaluation of biometric systems. 2012. Accessed March 17, 2024 at: http://www.intechopen.com/books/new-trends-and-developments-in-biometrics/evaluation-of-biometric-systems
- 10 Sarfraz N. Adermatoglyphia: barriers to biometric identification and the need for a standardized alternative. Cureus 2019; 11 (02) e4040
- 11 Bansal S, Jinwala P, Asati V. et al. Assessment of knowledge about palliative care among registered nursing professionals: a prospective cross-sectional study in a tertiary care hospital in central India. Asian Pacific J Cancer Care 2023; 8 (04) 709-713